Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_141e28d395d450be2e61d82fed823240 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e42fc3a2fce5ba26da8224104c1710 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72d7c12aa7af8af6163b26a43cc4b8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0adc5f302707963055f8b51fbf87a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24045088dd1a62a50d69b24ed30f1e71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7369cca268aa2bd554c89b081f3bb0b2 |
publicationDate |
2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130044839-A |
titleOfInvention |
Anticancer composition comprising a hydroxymethoxy benzochalcone compound as an active ingredient |
abstract |
The present invention relates to a hydroxymethoxybenzochalcone compound represented by the following Chemical Formula 1 having an effect of inhibiting cell cycle progression and cell growth ability by increasing the amount of cell cycle progression inhibiting protein p21 and an anticancer composition comprising the same. . [Formula 1] Hydroxymethoxybenzochalcone compound according to the present invention has excellent anticancer effect through the overexpression of p21 can be usefully used as a cancer prevention and treatment agent. |
priorityDate |
2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |